** Shares of Avenira AEV.AX rise 28.6% to A$0.009, their highest levels since Feb 13
** Stock eyes best trading session since late July 2024, if current gains hold
** The specialty miner says it has secured an investment from a unit of China-based Sichuan Hebang Biotechnology 603077.SS, co's largest shareholder
** The investment comprises a A$7.567 mln ($4.77 mln) placement at an issue price of A$0.007, in line with stock's last close
** Sichuan Hebang also agrees to provide unsecured draw-down loan facility
** Funds to be used to advance co's Wonarah Direct Shipping Ore (DSO) phosphate project in the Northern Territory
** Stock up 5.9% YTD, including current session's moves
($1 = 1.5853 Australian dollars)
(Reporting by Nikita Maria Jino in Bengaluru)
((Nikita.Jino@thomsonreuters.com;))
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。